Listar GI- GRINCAR - Artigos por autor "Cequier, Ángel"
Mostrando ítems 1-12 de 12
-
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Raña-Míguez, Paula; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory; Marín, Francisco (NLM, 2019-12-24)[Abstract] Background. Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ... -
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ... -
Current antiarrhythmic therapy for nonvalvular atrial fibrillation in Spain: data from the FANTASIIA registry
Roldán, Inmaculada; Anguita, Manuel; Marín, Francisco; Quesada, María Angustias; Camacho Siles, José; Peinado, Rafael; Bertomeu, Vicente; Cequier, Ángel; Badimón, Lina; Muñiz, Javier (Elsevier, 2015-06-18)[Abstract] Introduction and objectives. Recently, there have been many developments in the management of nonvalvular atrial fibrillation, antiarrhythmic and anticoagulant therapy, and nonpharmacological treatment, but these ... -
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study
Ruiz Ortiz, Martín; Muñiz, Javier; Esteve-Pastor, María Asunción; Marín, Francisco; Roldán, Inmaculada; Cequier, Ángel; Martínez-Sellés, Manuel; González Saldivar, Hugo; Bertomeu, Vicente; Anguita, Manuel (SAGE, 2020-03-31)[Abstract] Objective: To describe major events at follow up in octogenarian patients with atrial fibrillation (AF) according to anticoagulant treatment: direct oral anticoagulants (DOACs) versus vitamin K antagonists ... -
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation: the FANTASIIA study
Anguita-Sánchez, Manuel; Bertomeu-Martínez, Vicente; Ruiz-Ortiz, Martín; Cequier, Ángel; Roldán-Rabadán, Inmaculada; Muñiz, Javier; Badimón, Lina; Esteve-Pastor, María Asunción; Marín Ortuño, Francisco (Elsevier, 2019-05-31)[Abstract] Introduction and objectives: To compare the long-term results of direct oral anticoagulants (DOAC) vs vitamin K antagonists (VKA) in real-world-patients with nonvalvular atrial fibrillation (NVAF) in a nationwide, ... -
Impact of integrated care management on clinical outcomes in atrial fibrillation patients: a report from the FANTASIIA Registry
Esteve-Pastor, María Asunción; Ruiz-Ortiz, Martín; Muñiz, Javier; Roldán Rabadán, Inmaculada; Otero García, Deborah; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y. H.; Marín, Francisco (Frontiers, 2022-05)[Abstract] Background: An integrated and holistic approach is increasingly advocated in patients with atrial fibrillation (AF), based on the “Atrial fibrillation Better Care (ABC) pathway: A, Avoid stroke with anticoagulation; ... -
In-hospital mortality due to acute myocardial infarction: relevance of type of hospital and care provided: RECALCAR study
Bertomeu-Martínez, Vicente; Cequier, Ángel; Bernal, José Luis; Alfonso, Fernando; Anguita, Manuel; Muñiz, Javier; Barrabés, José A.; García-Dorado, David; Goicolea, Javier; Elola, Francisco J. (Elsevier, 2013-09-14)[Abstract] Introduction and objectives. To investigate the relationship between in-hospital mortality due to acute myocardial infarction and type of hospital, discharge service, and treatment provided. Methods. Retrospective ... -
Quality of anticoagulation with vitamin K antagonists
Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ... -
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, Marco; Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Roldán Rabadán, Inmaculada; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ... -
Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry
García-Fernández, Amaya; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu- Martínez, Vicente; Badimón, Lina; Otero, Déborah; Anguita, Manuel; Lip, Gregory; Marín, Francisco (Taylor & Francis Group, 2020-06-17)[Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ... -
Satisfaction with medical care in patients with atrial fibrillation treated with vitamin k antagonists versus new oral anticoagulants
Anguita, Manuel; Marín, Francisco; Roldán, Inmaculada; Cequier, Ángel; Bertomeu, Vicente; Muñiz, Javier (Elsevier, 2015-04-27) -
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...